Core Outcome Set for IgE-mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study 'COMFA'.
Anastasia DemidovaKarl Philipp DrewitzParisut KimkoolNikolina BanjaninVladyslava BarzylovychErna BotjesIndia CapperMary Anne R CastorPasquale ComberiatiEmma E CookJoana CostaDerek K ChuMichelle M EpsteinAudrey Dunn GalvinMattia GiovanniniFrédéric GirardMichael A GoldingMatthew J GreenhawtDespo IerodiakonouChristina J JonesEkaterina KhalevaRebecca C KnibbMelahat Sedanur Macit-ÇelebiDouglas Paul MackIsabel MafraMary Jane MarchisottoDragan MijakoskiNikita A NekliudovCevdet ÖzdemirNandinee PatelEkaterina PazukhinaJennifer Lisa Penner ProtudjerPablo Rodríguez Del RíoJelena RoometPatrick SammutAnn-Marie Malby SchoosAnita Fossaluzza SchopferFallon SchultzNina SeylanovaIsabel J SkypalaMartin SørensenSasho StoleskiEva StylianouJulia E M UptonWillem van de VeenJon GenuneitRobert J BoyleChristian J ApfelbacherDaniel Munblitnull nullPublished in: Allergy (2024)
In addition to the mandatory reporting of adverse events for FA clinical trials or observational studies of interventions, allergic symptoms and quality of life should be measured as core outcomes. Future work by COMFA will define how best to measure these core outcomes.